Prostate Cancer Recurrent Clinical Trial
Official title:
[177Lu]Lu-PSMAI&T Radioligand Therapy (PSMA-RLT) for Patients With Prostate Cancer and Biochemical But Not Radio-morphological Local Recurrence After Primary Therapy With Curative Intent: A Prospective Phase II Pilot Study
Prospective single-center one-arm phase II study in patients with prostate cancer and confirmed biochemical recurrence (BCR) with PSA of ≥ 0.2 ng/ml after radical prostatectomy (RP) or PSA > nadir + 2ng/ml after radiotherapy (RT) but not radio-morphological local recurrence after primary therapy with curative intent receive systemic therapy with only 2 cycles of highly standardized (3 GBq in first cycle and 6 GBq in the second cycle) PSMA-RLT at 6-week intervals.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT05848011 -
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT02562131 -
PET-MR-PSA Prostate Cancer Recidive Study
|
||
| Completed |
NCT04134130 -
The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer
|
N/A | |
| Recruiting |
NCT03507595 -
Evaluation of the Metastasis and Recurrence of Prostate Cancer
|
||
| Active, not recruiting |
NCT04983628 -
Molecular Profiling in Prostate Cancer
|
||
| Completed |
NCT03739684 -
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT04686188 -
Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
|
||
| Active, not recruiting |
NCT04114825 -
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05646550 -
Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT04876755 -
MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT01938339 -
Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
|
N/A | |
| Completed |
NCT01857037 -
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanningâ„¢ and MRI
|
N/A | |
| Active, not recruiting |
NCT03444844 -
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT04102553 -
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
|
Phase 3 | |
| Completed |
NCT03443609 -
Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer
|
N/A | |
| Recruiting |
NCT05036226 -
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT04324983 -
Identification of Predictive Biomarkers
|
N/A | |
| Completed |
NCT02176161 -
Metformin Prostate Cancer Adjuvant Trial
|
Phase 2 | |
| Active, not recruiting |
NCT04734184 -
A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
|
Phase 3 |